PR97898

BANGKOK, Sept. 19, 2022 /PRNewswire=KYODO JBN/

On September 19, HUAWEI CONNECT 2022 kicked off in Bangkok, Thailand. At the

event, Mr. Ken Hu, Rotating and Acting Chairman of Huawei, delivered a keynote

titled "Unleash Digital," where he talked about how the company is helping

organizations make the most of cloud for leapfrog development.

During his speech, Mr. Ken Hu spoke about how the First Affiliated Hospital of

the Medical School at Xi'an Jiaotong University used AI to expedite

pharmaceutical R&D and new drug discovery.

In the pharmaceutical industry, an average of over 1 billion USD and 10 years

is needed to put a new drug on the market, from development to approval. While

developing antibiotics, it has been noted that resistant bacteria are sometimes

discovered even before newly developed antibiotics finish clinical trials.

By using an AI-aided drug design service powered by Huawei Cloud's Pangu Drug

Molecule Model, Professor Liu Bing of the First Affiliated Hospital of the

Medical School at Xi'an Jiaotong University and his team developed a new

broad-spectrum antimicrobial drug in just one month, and R&D costs were slashed

by 70%.

A major challenge in new drug discovery lies in the screening of hundreds of

millions of existing drug molecules. Traditionally, drug screening was

performed by experts in labs, which was costly, slow, and had a high failure

rate.

The Huawei Cloud Pangu Drug Molecule Model has been trained using the data of

1.7 billion drug-life molecules, and can predict the physicochemical properties

of drug compounds and score them based on their druglikeness. Researchers can

then do targeted experiments to verify drug compounds that have the highest

scores.

Moreover, the Pangu Drug Molecule Model's molecular structure optimizer can be

used to optimize the structure of lead compounds, minimizing the potential side

effects of the new drugs on normal human cells.

Today, cloud has become an important carrier for digital companies. Huawei

Cloud provides four development pipelines, including ModelArts the AI

development pipeline, which customers and partners from all industries can

access on demand, so they can leave the technical side of digital innovation to

Huawei Cloud, and concentrate more on what matters most to them.

SOURCE: HUAWEI CLOUD

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=429672

   Caption: Mr. Ken Hu delivering his speech at HUAWEI CONNECT 2022